# Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

> **NCT00537940** · PHASE4 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 482 (actual)

## Conditions studied

- Epilepsy
- Partial Seizure Disorder
- Epilepsies, Partial
- Complex Partial Seizure Disorder

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT00537940
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 482 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537940, "Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00537940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*